Released on: July 7, 2008, 7:45 am

Press Release Author: Mr Nick Greer

Industry: Pharmaceuticals

Press Release Summary: Blackstar Internet Ltd today announced the launch of
www.pharmaetrade.com
The Worlds Premier Pharmaceutical Trading Platform


Press Release Body:
7th July 2008, Staffordshire England

Blackstar Internet Ltd announces the launch of a New Online Pharmaceutical Trading
Platform

Blackstar Internet Ltd today announced the launch of www.pharmaetrade.com
The Worlds Premier Pharmaceutical Trading Platform

About Pharmaetrade.com

Pharmaetrade.com has been designed for manufacturers, distributors, wholesalers,
import/exporters and retailers of branded drugs, Generics, medical equipment and OTC
products.
Pharmaetrade.com is the only industry specific online platform that allows you to
advertise your company, post stock requirements and stock for sale, keep up to date
with industry news, promote new products, form new business relationships in a
global arena, Increase your margins & volumes and stay in touch with your client
base using a free online messenger service all from one point.

Nick Greer Managing Director said ‘The launch of Pharmaetrade.com is testament to
our commitment to bring a world class Pharmaceutical Trading Platform to market
supported by our value added services’

Parallel distribution of pharmaceuticals, as well as for other goods, stems from
price differentials between different national markets within the European Economic
Area (EEA). Parallel distributors buy products marketed by the original manufacturer
at a lower price in one country and sell them at a higher price in another country.
Such a form of trade is legal by virtue of the rule of regional exhaustion of
trademark rights applied in the EU and the EEA.
Parallel distribution of medicines provides significant savings to governments,
health insurers and patients by making original, innovative medicines available at a
lower cost.
A 2005 study of only four EU countries found that parallel distribution generated
direct savings to patients and social health insurance systems in excess of €440
million in 2004. It also found that there are significant indirect savings through
the competitive effect of parallel distribution.
The British, German, Dutch, Danish, Swedish and Norwegian healthcare systems make
direct savings of hundreds of million of Euros every year thanks to parallel-traded
medicines.
To these direct savings must be added a much higher amount of indirect savings as a
result of parallel trade being the only form of price competition to monopolistic
patent-protected brands.
Without parallel trade, healthcare contributions by the tax-payer would be higher
and many patients would face paying more at a time of growing need for prescribed
medicines.

With newer and improved medicines increasingly expensive, and with the range of
parallel-traded products expanding with more countries involved as parallel trade
destinations, there is a huge potential for savings to increase - as long as
supplies are not jeopardised by artificial barriers - such as quota systems or dual
pricing by manufacturers - to free movement within the EU.

Source: European Association of Euro-Pharmaceutical Companies
http://www.eaepc.org

Pharmaetrade.com is a service provided by:
Blackstar Internet Ltd
Unit 12 Hampton Street,
Joiners Square Industrial Estate,
Stoke-On-Trent,
Staffordshire
ST1 3EX

Tel: +44 (0) 1782 279333
Fax: +44 (0) 1782 265300

E-mail: info@pharmaetrade.com

M.D. Nick Greer



Web Site: http://www.pharmaetrade.com/

Contact Details: Pharmaetrade.com is a service provided by:
Blackstar Internet Ltd
Unit 12 Hampton Street,
Joiners Square Industrial Estate,
Stoke-On-Trent,
Staffordshire
ST1 3EX

Tel: +44 (0) 1782 279333
Fax: +44 (0) 1782 265300

E-mail: info@pharmaetrade.com

M.D. Nick Greer